Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 1

Results: 26

The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 1, doi. 10.1634/theoncologist.2017-0519

By:

Subbiah, Vivek;
Kurzrock, Razelle

Publication type:

Article

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 96, doi. 10.1634/theoncologist.2017-0687

By:

Duma, Narjust;
Kothadia, Sejal M.;
Azam, Tariq U.;
Yadav, Siddhartha;
Paludo, Jonas;
Vera Aguilera, Jesus;
Gonzalez Velez, Miguel;
Halfdanarson, Thorvardur Ragnar;
Molina, Julian R.;
Hubbard, Joleen M.;
Go, Ronald S.;
Mansfield, Aaron S.;
Adjei, Alex A.

Publication type:

Article

Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New Rash.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 4, doi. 10.1634/theoncologist.2018-0434

By:

Patil, Pradnya D.;
Fernandez, Anthony P.;
Velcheti, Vamsidhar;
Tarhini, Ahmad;
Funchain, Pauline;
Rini, Brian;
Khasawneh, Mohamad;
Pennell, Nathan A.

Publication type:

Article

Perceptions of Oncologists About Sharing Clinic Notes with Patients.

Published in:

Oncologist, 2019, v. 24, n. 1, p. e46, doi. 10.1634/theoncologist.2018-0070

By:

McCleary, Nadine J.;
Healey, Michael J.;
Weng, Shicheng;
Song, Andrew B.;
Lederman, Ruth I.;
Ramelson, Harley Z.;
Wagner, Andrew J.;
Abel, Gregory A.

Publication type:

Article

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 14, doi. 10.1634/theoncologist.2017-0665

By:

Beatty, Gregory L.;
Shahda, Safi;
Beck, Thaddeus;
Uppal, Nikhil;
Cohen, Steven J.;
Donehower, Ross;
Gabayan, Afshin Eli;
Assad, Albert;
Switzky, Julie;
Zhen, Huiling;
Von Hoff, Daniel D.

Publication type:

Article

SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 9, doi. 10.1634/theoncologist.2018-0016

By:

D'Haene, Nicky;
Le Mercier, Marie;
Salmon, Isabelle;
Mekinda, Zita;
Remmelink, Myriam;
Berghmans, Thierry

Publication type:

Article

A Patient‐Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End‐of‐Life Discussions and Reduce Unwanted Health Care Costs

Published in:

Oncologist, 2019, v. 24, n. 1, p. 76, doi. 10.1634/theoncologist.2018-0238

By:

Goldberg, Stuart L.;
Paramanathan, Dhakshila;
Khoury, Raya;
Patel, Sharmi;
Jagun, Dayo;
Arunajadai, Srikesh;
DeVincenzo, Victoria;
Benito, Ruth Pe;
Gruman, Brooke;
Kaur, Sukhi;
Paddock, Scott;
Norden, Andrew D.;
Schultz, Eric V.;
Hervey, John;
Jordan, Terrill;
Goy, Andre;
Pecora, Andrew L.

Publication type:

Article

FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 103, doi. 10.1634/theoncologist.2018-0221

By:

Fashoyin‐Aje, Lola;
Donoghue, Martha;
Chen, Huanyu;
He, Kun;
Veeraraghavan, Janaki;
Goldberg, Kirsten B.;
Keegan, Patricia;
McKee, Amy E.;
Pazdur, Richard

Publication type:

Article

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 16, doi. 10.1634/theoncologist.2018-0452

By:

Del Rivero, Jaydira;
Edgerly, Maureen;
Ward, Jean;
Madan, Ravi A.;
Balasubramaniam, Sanjeeve;
Fojo, Tito;
Gramza, Ann W.

Publication type:

Article

Use of Antidepressant Medications Moderates the Relationship Between Depressive Symptoms and Hospital Length of Stay in Patients with Advanced Cancer.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 117, doi. 10.1634/theoncologist.2018-0096

By:

Wong, Risa L.;
El‐Jawahri, Areej;
D'Arpino, Sara M.;
Fuh, Charn‐Xin;
Johnson, P. Connor;
Lage, Daniel E.;
Irwin, Kelly E.;
Pirl, William F.;
Traeger, Lara;
Cashavelly, Barbara J.;
Jackson, Vicki A.;
Greer, Joseph A.;
Ryan, David P.;
Hochberg, Ephraim P.;
Temel, Jennifer S.;
Nipp, Ryan D.

Publication type:

Article

Expenditures on Oncology Drugs and Cancer Mortality‐to‐Incidence Ratio in Central and Eastern Europe.

Published in:

Oncologist, 2019, v. 24, n. 1, p. e30, doi. 10.1634/theoncologist.2018-0093

By:

Vrdoljak, Eduard;
Bodoky, Gyorgy;
Jassem, Jacek;
Popescu, Razvan;
Pirker, Robert;
Čufer, Tanja;
Bešlija, Semir;
Eniu, Alexandru;
Todorović, Vladimir;
Kopečková, Katerina;
Kurteva, Galia;
Tomašević, Zorica;
Sallaku, Agim;
Smichkoska, Snezhana;
Bajić, Žarko;
Sikic, Branimir

Publication type:

Article

A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 20, doi. 10.1634/theoncologist.2018-0464

By:

Kim, Miso;
Kim, Tae Min;
Keam, Bhumsuk;
Kim, Yu Jung;
Paeng, Jin Chul;
Moon, Kyung Chul;
Kim, Dong‐Wan;
Heo, Dae Seog

Publication type:

Article

Dramatic Response to Concurrent Anti‐PD‐1 Therapy and Radiation in Resistant Tumors with Sarcomatoid Differentiation.

Published in:

Oncologist, 2019, v. 24, n. 1, p. e49, doi. 10.1634/theoncologist.2018-0205

By:

Tolay, Sameer;
Nair, Ranjit;
McIntosh, Alyson F.;
Sopka, Dennis M.;
Nair, Suresh G.

Publication type:

Article

The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 54, doi. 10.1634/theoncologist.2018-0187

By:

Hendifar, Andrew E.;
Dhall, Deepti;
Strosberg, Jonathan R.

Publication type:

Article

Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 125, doi. 10.1634/theoncologist.2017-0583

By:

Azhar, Ahsan;
Kim, Yu Jung;
Haider, Ali;
Hui, David;
Balankari, Vishidha R.;
Epner, Margeaux Chiou;
Park, Minjeong;
Liu, Diane D.;
Williams, Janet;
Frisbee‐Hume, Susan E.;
Allo, Julio A.;
Bruera, Eduardo

Publication type:

Article

Impact of Guideline‐Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early‐Stage Breast Cancer.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 31, doi. 10.1634/theoncologist.2018-0076

By:

Williams, Courtney P.;
Kenzik, Kelly M.;
Azuero, Andres;
Williams, Grant R.;
Pisu, Maria;
Halilova, Karina I.;
Ingram, Stacey A.;
Yagnik, Supriya K.;
Forero, Andres;
Bhatia, Smita;
Rocque, Gabrielle B.

Publication type:

Article

Definitive Radiotherapy in Invasive Vaginal Carcinoma: A Systematic Review.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 132, doi. 10.1634/theoncologist.2017-0546

By:

Guerri, Sara;
Perrone, Anna M.;
Buwenge, Milly;
Ferioli, Martina;
Macchia, Gabriella;
Tagliaferri, Luca;
Ferrandina, Gabriella;
Galuppi, Andrea;
Andrulli, Angela D.;
Frakulli, Rezarta;
Cammelli, Silvia;
Arcelli, Alessandra;
De Iaco, Pierandrea;
Morganti, Alessio G.

Publication type:

Article

Outcome of First‐Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 110, doi. 10.1634/theoncologist.2017-0574

By:

van Maldegem, Annemiek;
Conley, Anthony P.;
Rutkowski, Piotr;
Patel, Shreyaskumar R.;
Lugowska, Iwona;
Desar, Ingrid M.E.;
Bovée, Judith V.M.G.;
Gelderblom, Hans

Publication type:

Article

Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow‐Up Care and Treatment: Perspectives of Human Immunodeficiency Virus‐Positive Women and Health Care Practitioners in Tanzania.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 69, doi. 10.1634/theoncologist.2017-0444

By:

Bateman, Lori Brand;
Blakemore, Shaundra;
Koneru, Alaya;
Mtesigwa, Thereza;
McCree, Renicha;
Lisovicz, Nedra F.;
Aris, Eric A.;
Yuma, Safina;
Mwaiselage, Julius D.;
Jolly, Pauline E.

Publication type:

Article

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First‐line Therapy (KCSG ST10‐01).

Published in:

Oncologist, 2019, v. 24, n. 1, p. 18, doi. 10.1634/theoncologist.2018-0142

By:

Lee, Keun‐Wook;
Maeng, Chi Hoon;
Kim, Tae‐You;
Zang, Dae Young;
Kim, Yeul Hong;
Hwang, In Gyu;
Oh, Sang Cheul;
Chung, Joo Seop;
Song, Hong Suk;
Kim, Jin Won;
Jeong, Su Jin;
Cho, Jae Yong

Publication type:

Article

Integrative 3′ Untranslated Region‐Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple‐Negative Breast Cancer.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 22, doi. 10.1634/theoncologist.2017-0609

By:

Wang, Lei;
Hu, Xin;
Wang, Peng;
Shao, Zhi‐Ming

Publication type:

Article

Strategies for Recognizing and Managing Immune‐Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 86, doi. 10.1634/theoncologist.2018-0045

By:

Vardhana, Santosha;
Cicero, Kara;
Velez, Moises J.;
Moskowitz, Craig H.

Publication type:

Article

10‐Year Results of Therapeutic Ratio by Intensity‐Modulated Radiotherapy Versus Two‐Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.

Published in:

Oncologist, 2019, v. 24, n. 1, p. e38, doi. 10.1634/theoncologist.2017-0577

By:

Chen, Lei;
Zhang, Yuan;
Lai, Shu‐Zhen;
Li, Wen‐Fei;
Hu, Wei‐Han;
Sun, Rui;
Liu, Li‐Zhi;
Zhang, Fan;
Peng, Hao;
Du, Xiao‐Jing;
Lin, Ai‐Hua;
Sun, Ying;
Ma, Jun

Publication type:

Article

Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 47, doi. 10.1634/theoncologist.2017-0651

By:

Imaoka, Hiroshi;
Sasaki, Mitsuhito;
Takahashi, Hideaki;
Hashimoto, Yusuke;
Ohno, Izumi;
Mitsunaga, Shuichi;
Watanabe, Kazuo;
Umemoto, Kumiko;
Kimura, Gen;
Suzuki, Yuko;
Kan, Motoyasu;
Ikeda, Masafumi

Publication type:

Article

Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 62, doi. 10.1634/theoncologist.2017-0570

By:

Lange, Marie;
Heutte, Natacha;
Noal, Sabine;
Rigal, Olivier;
Kurtz, Jean‐Emmanuel;
Lévy, Christelle;
Allouache, Djelila;
Rieux, Chantal;
Lefel, Johan;
Clarisse, Bénédicte;
Leconte, Alexandra;
Veyret, Corinne;
Barthélémy, Philippe;
Longato, Nadine;
Tron, Laure;
Castel, Hélène;
Eustache, Francis;
Giffard, Bénédicte;
Joly, Florence

Publication type:

Article

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 38, doi. 10.1634/theoncologist.2017-0622

By:

Capdevila, Jaume;
Teulé, Alexandre;
Barriuso, Jorge;
Castellano, Daniel;
Lopez, Carlos;
Manzano, Jose Luis;
Alonso, Vicente;
García‐Carbonero, Rocío;
Dotor, Emma;
Matos, Ignacio;
Custodio, Ana;
Casanovas, Oriol;
Salazar, Ramon

Publication type:

Article